Terms: = Breast cancer AND PR, PGR, progesterone receptor
15036 results:
1. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
[No Abstract] [Full Text] [Related]
2. The evolvement of breast cancer therapies: What we have done and where all these head off.
Nurlaila I; Pambudi S
Saudi Med J; 2024 Apr; 45(4):331-340. PubMed ID: 38657992
[TBL] [Abstract] [Full Text] [Related]
3. [Not Available].
Lokøy IK; Bakken IS; Wik E; Stefansson IM
Tidsskr Nor Laegeforen; 2024 Apr; 144(5):. PubMed ID: 38651722
[TBL] [Abstract] [Full Text] [Related]
4. [Case Report of Occult breast cancer with Triple Negative Subtype].
Tanaka Y; Ohshima Y; Fukaya Y; Hosoya K; Wakahara M
Gan To Kagaku Ryoho; 2024 Apr; 51(4):421-423. PubMed ID: 38644310
[TBL] [Abstract] [Full Text] [Related]
5. Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.
Meng X; Hao F; Wang N; Qin P; Ju Z; Sun D
BMC Med Res Methodol; 2024 Apr; 24(1):90. PubMed ID: 38637725
[TBL] [Abstract] [Full Text] [Related]
6. breast cryoablation for the palliative treatment of indolent subtype of multicentric triple-negative breast cancer.
Huang ML; Lane DL; Bomar H; Kuerer H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38627044
[TBL] [Abstract] [Full Text] [Related]
7. Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Bahador M; Saeedi Nejad M; Dabiri S; Larizadeh MH; Soofiabadi MF
J Egypt Natl Canc Inst; 2024 Apr; 36(1):12. PubMed ID: 38616231
[TBL] [Abstract] [Full Text] [Related]
8. The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.
Ding XH; Xiao Y; Chen F; Liu CL; Fu T; Shao ZM; Jiang YZ
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38602320
[TBL] [Abstract] [Full Text] [Related]
9. Significance of Estrogen/progesterone receptor Expression in Metaplastic breast Carcinoma.
Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
[TBL] [Abstract] [Full Text] [Related]
10. Design and methods of the mobile assessment of cognition, environment, and sleep (MACES) feasibility study in newly diagnosed breast cancer patients.
Derbes R; Hakun J; Elbich D; Master L; Berenbaum S; Huang X; Buxton OM; Chang AM; Truica CI; Sturgeon KM
Sci Rep; 2024 Apr; 14(1):8338. PubMed ID: 38594369
[TBL] [Abstract] [Full Text] [Related]
11. [Comparative immunohistochemistry study of different antibodies clones for detection of breast cancer markers (estrogen receptor, progesterone receptor, HER2/neu, Ki-67)].
Kalinin DV; Samoylova DV; Danilova NV; Germanovich NY; Kuznetsova OA; Zavalishina LE
Arkh Patol; 2024; 86(2):14-20. PubMed ID: 38591902
[TBL] [Abstract] [Full Text] [Related]
12. Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer.
Bartoloni S; Pescatori S; Bianchi F; Cipolletti M; Acconcia F
Sci Rep; 2024 Apr; 14(1):8200. PubMed ID: 38589728
[TBL] [Abstract] [Full Text] [Related]
13. Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit.
Engström T; Ekholm M; Fernö M; Lundgren C; Nordenskjöld B; Stål O; Bendahl PO; Tutzauer J; Rydén L
Acta Oncol; 2024 Apr; 63():125-136. PubMed ID: 38587062
[TBL] [Abstract] [Full Text] [Related]
14. Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer: a real-world retrospective single-institutional study in China.
Peng DM; Li J; Qiu JX; Zhao L
World J Surg Oncol; 2024 Apr; 22(1):88. PubMed ID: 38582875
[TBL] [Abstract] [Full Text] [Related]
15. Effect of tumor-infiltrating immune cells (mast cells, neutrophils and lymphocytes) on neoadjuvant chemotherapy response in breast carcinomas.
Okcu O; Öztürk Ç; Yalçın N; Yalçın AC; Şen B; Aydın E; Öztürk AE
Ann Diagn Pathol; 2024 Jun; 70():152301. PubMed ID: 38581761
[TBL] [Abstract] [Full Text] [Related]
16. Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis.
Bahrin NWS; Matusin SNI; Mustapa A; Huat LZ; Perera S; Hamid MRWHA
Syst Rev; 2024 Apr; 13(1):100. PubMed ID: 38576013
[TBL] [Abstract] [Full Text] [Related]
17. Case report: Primary vulvar adenocarcinoma of mammary gland type-its genetic characteristics by focused next-generation sequencing.
Hu L; Tiesinga J
Pathol Oncol Res; 2024; 30():1611376. PubMed ID: 38572338
[TBL] [Abstract] [Full Text] [Related]
18. Enhanced protein-metabolite correlation analysis: To investigate the association between Staphylococcus aureus mastitis and metabolic immune pathways.
Chen K; Hu B; Ren J; Deng X; Li Q; Zhang R; Zhang Y; Shen G; Liu S; Zhang J; Lu P
FASEB J; 2024 Apr; 38(7):e23587. PubMed ID: 38568835
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study.
Peng J; Hong Y; Chen Q; Xu F; Zhang D; Yao J; Zou Q; Yuan L; Li L; Long Q; Liao L; Liu M; Liu X; Wang S; Yi W
Front Endocrinol (Lausanne); 2024; 15():1347762. PubMed ID: 38567311
[TBL] [Abstract] [Full Text] [Related]
20. LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cells.
Ramírez-Cuéllar J; Ferrari R; Sanz RT; Valverde-Santiago M; García-García J; Nacht AS; Castillo D; Le Dily F; Neguembor MV; Malatesta M; Bonnin S; Marti-Renom MA; Beato M; Vicent GP
EMBO J; 2024 May; 43(9):1770-1798. PubMed ID: 38565950
[TBL] [Abstract] [Full Text] [Related]
[Next]
